All News about Aldeyra Therapeutics, Inc. - Common Stock



Via Benzinga

Aldeyra's ADX-2191 Aces Late-Stage Study In Rare Vision Disorder
October 06, 2022
Via Benzinga









Via Benzinga









Important Biotech Catalysts For September 14, 2022 - End Of The Day Summary
September 14, 2022
Via Benzinga


Aldeyra Therapeutics to Participate in Upcoming Investor Conferences
September 07, 2022
Via Business Wire





Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.